effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 16, Issue 4, 2005, Pages 257-274

  Pari, Leelavinothan ^a   Murugan, Pidaran ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

anti diabetic; carbohydrate metabolic enzymes; diabetes mellitus

Indexed keywords

CURCUMIN; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOGEN; IDITOL DEHYDROGENASE; INSULIN; PLANT EXTRACT; STREPTOZOCIN; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIVER; MALE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATE METABOLISM; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; GLYCOGEN; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; INSULIN; LIVER; MALE; RATS; RATS, WISTAR;

EID: 30644469766     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2005.16.4.257     Document Type: Article

References (46)

1. Devendra, D, Liu, E, Eisenbarth, GS. Type 1 diabetes recent developments. BMJ 2004; 328: 750–754.
2. King, H, Aubert, R, Herman, WH. Global burden of diabetes 1995–2025. Diabetes Care 1998; 21: 1414–143.
3. Reaven, GM. Role of insulin resistance in human diseases. Diabetes 1998; 37: 1597–1607.
4. Kameswara Rao, B, Appa Rao, CH. Hypoglycemic and antihyperglycemic activity of alternifolium (Wt.) WaLp. Seed extracts in normal and diabetic rats. Phytomedicine 2001; 8: 88–93.
5. Halim Eshrat, M, Ali Hussain. Hypoglycemic, hypolipidemic and antioxidant properties of combination of curcumin from Curcuma longa, linn, and partially purified product from Abroma augusta, Linn, in streptozotocin induced diabetes. Ind J Clin Biochem 2002; 17: 33–43.
6. Mary, E, Waltner-Law, Xiaohui L Wang, Brian K Law, Robert K Hall, Masao Nawano, Daryl K. Granner. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 2002; 277: 34933–34940.
7. Al-Shamaony, L, Al-Kharzraji, SM, Twaiji, SM. Hypoglycemic effect of Artemisia heba alba IL Effect of a valuable extract on some blood parameters in diabetic animals. J Ethanopharmacol 1994; 43: 167.
8. Arun, N, Nalini, N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Food Hum Nut 2002; 57: 41–51.
9. Suresh Babu, P, Srinivasan, K. Hypolipidemic action of curcumin, the active principle of turmeric (curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 1997; 166; 169–175.
10. Suresh Babu, P, Srinivasan, K. Amelioration of renal lesions associated with diabetes by dietery curcumin in streptozotocin induced diabetic rats. Mol Cell Biochem 1998; 181: 87–96.
11. Sajithlal, GB, Chlthra, P, Gowri, C. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 1998; 56: 1607–1614.
12. Majeed, M, Badmaev, V, Uma, S, Rajenderan, JR. Curcumlnolds: Antioxidant phytonutrients. New Jersey, USA: Nutriscience publishers, 1995; 1–24.
13. Sugiyama, Y, Kawakishi, S, Osawa, T. Involvement of the β-diketone moiety in the antioxidant mechanism of tetrahydrocurcuminoids. Biochem Pharmacol 1996; 52: 519–525.
14. Ravidranath, V, Chandrasekara, N. Absorption and tissue distribution of curcumin in rats. Toxicology 1980; 16: 259–265.
15. Osawa, T, Sugiyama, Y, Inayoshi, M, Kawakishi, S. Antioxidant activity of tetrahydrocurcuminoids. Biosci Biotech Biochem 1995; 59: 1609–1612.
16. Lin, JK, Lin-Shiau, SY. Mechanisms of cancer chemoprevention by curcumin. Proc Natl Sei Counc Repub China B 2001; 25: 59–66.
17. Nakamura, Y. Inhibitory effect and Tetrahydrocurcuminoids on the tumor promoter induced reactive oxygen species generation in leucocyte, in vitro and in vivo. Jap J Cancer Res 1998; 89: 361–370.
18. Hong, J, Bose, M, Ju, J, Ryu, JH, Chen, X, Sang, S, et al Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxy-genases and 5-lipoxygenase. Carcinogenesis 2004; 25: 1671–1679.
19. Naito, M, Wu, X, Normura, H, Kodama, M, Kato, Y, Osaswa, T. The protective effect of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb 2002; 9: 243–250.
20. Pari, L, Murugan, P. Protective role of tetrahydrocurcumin against erythromycin estolate induced hepatotoxicity. Pharmacol Res 2004; 49: 481–486.
21. Satyavathi, GV, Gupta, AK. Tandon, N. Medicinal plants of India, ICMR publications New Delhi 1987; 2: p 533.
22. John A. Lott, Turner, K. Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem 1975; 21/12: 1754–1760.
23. Du Vigneaud, V, Karr, WG. Carbohydrates utilization rate of disappearance of D-glucose from the blood. J Biol Chem 1925; 66: 281–300.
24. Drabkin, DL, Austin, JM. Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem 1932; 98: 719–733.
25. Sudhakar Nayak, S, Pattabiraman, TN. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chem Acta 1981; 109: 267–274.
26. Bannon, P. Effect of pH on the elimination of the labile fraction of glycosylated haemoglobin. Clin Chem 1982; 28: 2183.
27. Morales, MA, Jabbagy, AJ, Tenenzi, HP. Mutations affecting accumulation of glycogen. Neurospora News Lett 1973; 20: 24–25.
28. Brandstrup, N, Kirk, JE, Bruni, C. Determination of hexokinase in tissues. J Gerontol 1957; 12: 166–171.
29. Ellis, HA, Kirkman, HN. A colorimetric method for assay of erythrocyte gluocse-6-phosphate dehydrogenase. Proc Soc Exp Biol Med 1961; 106: 607–609.
30. Koida, H, Oda, T. Pathological occurrence of glucose-6-phosphatase in liver disease. Clin Chim Acta 1959; 4: 554–561.
31. Fiske, CH, Subbarow, J. The colorimetric determination of phosphorous. J Biol Chem 1925; 66: 375–400.
32. Gancedo, JM, Gancedo, C. Fructose-1,6-bisphosphatase, phospho-fructokinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeasts. Arch Microbiol 1971; 76: 132–138.
33. ndedition, 1974; 569–573.
34. Duncan, BD. Multible range test for correlated and heteroscedastic means. Biometrics 1957; 13: 359–364.
35. Home, PD. Towards a new classification for diabetes: American view. Diabetes News 1998; 29: 1–3.
36. Shulman, GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171–176.
37. Alberti, KGMM, Press, CM. In: Keen, H, Jarre, J, eds, The Biochemistry and the Complications of Diabetes. New York, NY, USA: Edward Arnold Publishers; 1982; 231–270.
38. Koenig, RJ, Peterson, CM, Jones, RL, Saudek, C, Lehrman, M, Cerami, A. Correlation of glucose regulation and haemoglobin A1 C in diabeticmellitus. N Engl J Med 1976; 295: 417–420.
39. Sheela, GC, Augusti, KT. Antidiabetic effect of S-allyl cysteine sulphoxide isolated from garlic Allium Sativum Linn. Ind J Exp Biol 1992; 30: 523–526.
40. Weber, G, Convery, HJH. Insulin: Inducer of gIucose-6-phosphate dehydrogenase. Life Sci 1966; 5: 1136–1146.
41. Saraswathi Panneerselvam, R, Govindaswamy, S. Effect of sodium molybdate on carbohydrate metabolizing enzymes in alloxan-induced diabetic rats. J Nut Biochem 2002; 13: 21–26.
42. Bopanna, KN, Kannan, J, Sushma, G, Balaraman, R. Antidiabetic and antihyperlipidemic effects of Neem seed kernel powder on alloxan diabetic rabbits. Ind J Pharmacol 1997; 29: 162–167.
43. Prince, PSM, Menon, VP, Pari, L. Effect of Syzigium cumini extracts on hepatic hexokinase and glucose-6-phosphatase in experimental diabetes. Phytother Res 1997; 11: 529–531.
44. Venkateswaran, S, Pari, L. Effect of Coccinia indica on blood glucose, insulin and hepatic key enzymes in experimental diabetes. Pharm Biol 2002; 40: 165–170.
45. Pari, L, Latha, M. Antihyperglycaemic Effect of Scoparia dulcis: Effect on key metabolic enzymes of carbohydrate metabolism in streptozotocin induced diabetes. Pharmaceutical Biology 2004; 42: 1–7.
46. Brownlee, M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992; 15: 1835–1843.